✦ LIBER ✦

Tamoxifen response following no response to orchiectomy in metastatic male breast cancer: A case report

✍ Scribed by Dennis A. Hiluard; David W. Wilbur; Elber S. Camacho

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 154 KB
Volume: 25
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930250112

No coin nor oath required. For personal study only.

✦ Synopsis

A male patient with advanced breast cancer had no response to orchiectomy but subsequently enjoyed a 17-month partial response to tamoxifen 10 mg B.I.D. His tumor estrogen receptor (ER) protein was 555 fmol proteinhl cytosol. The potential role of ER determinations in the selection of therapy for advanced male breast cancer is discussed.

📜 SIMILAR VOLUMES

Response to paclitaxel and carboplatin i

Response to paclitaxel and carboplatin in metastatic salivary gland cancer: A case report

✍ Janet C. Ruzich; Marlyn C. Ciesla; Joseph I. Clark 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract ## Background Malignant tumors of the salivary gland are rare entities that are treated primarily by surgical resection. For patients with recurrent or unresectable disease, options include radiation therapy or chemotherapy; however, responses are few and of short duration. Patients wi

Estrogen receptor (ER) and progesterone

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

✍ Richard M. Elledge; Stephanie Green; Reginald Pugh; D. Craig Allred; Gary M. Cla 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB 👁 2 views

Results of estrogen receptor (ER) and progesterone receptor (PgR) ligand-binding assays (LBAs) are strongly correlated with ER and PgR by immuno-histochemistry (IHC). To investigate whether ER and PgR by IHC are also strongly correlated with tamoxifen response, time to treatment failure (TTF) and ov